226 related articles for article (PubMed ID: 19199918)
1. Obesity: pathophysiology and clinical management.
Gurevich-Panigrahi T; Panigrahi S; Wiechec E; Los M
Curr Med Chem; 2009; 16(4):506-21. PubMed ID: 19199918
[TBL] [Abstract][Full Text] [Related]
2. Drug treatment of obesity.
Bray GA
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Apr; 13(1):131-48. PubMed ID: 10932681
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
4. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
5. A concise review on the therapeutics of obesity.
Bray GA
Nutrition; 2000 Oct; 16(10):953-60. PubMed ID: 11054601
[TBL] [Abstract][Full Text] [Related]
6. Treatment of obesity: an update on anti-obesity medications.
Halpern A; Mancini MC
Obes Rev; 2003 Feb; 4(1):25-42. PubMed ID: 12608525
[TBL] [Abstract][Full Text] [Related]
7. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of appetite suppression: implication for the treatment of obesity.
Halford JC
Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637
[TBL] [Abstract][Full Text] [Related]
9. [The pharmacotherapy of obesity].
Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
[TBL] [Abstract][Full Text] [Related]
10. Regulation of food intake and the development of anti-obesity drugs.
Chen Y
Drug Discov Ther; 2016; 10(2):62-73. PubMed ID: 27063550
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of obesity: targets and perspectives.
Chiesi M; Huppertz C; Hofbauer KG
Trends Pharmacol Sci; 2001 May; 22(5):247-54. PubMed ID: 11339976
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in the pharmacological management of obesity.
Carek PJ; Dickerson LM
Drugs; 1999 Jun; 57(6):883-904. PubMed ID: 10400403
[TBL] [Abstract][Full Text] [Related]
13. New and emerging drug molecules against obesity.
George M; Rajaram M; Shanmugam E
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009
[TBL] [Abstract][Full Text] [Related]
14. [A practicing physician's view on obesity].
Juhász A; Katona E; Csongrádi E; Paragh G
Orv Hetil; 2006 Apr; 147(13):579-90. PubMed ID: 16623440
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological approaches for the treatment of obesity.
Fernández-López JA; Remesar X; Foz M; Alemany M
Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic options for the treatment of obesity.
Campbell ML; Mathys ML
Am J Health Syst Pharm; 2001 Jul; 58(14):1301-8. PubMed ID: 11471477
[TBL] [Abstract][Full Text] [Related]
17. Antiobesity therapy: emerging drugs and targets.
Das SK; Chakrabarti R
Curr Med Chem; 2006; 13(12):1429-60. PubMed ID: 16719787
[TBL] [Abstract][Full Text] [Related]
18. Strategies and potential molecular targets for obesity treatment.
Campfield LA; Smith FJ; Burn P
Science; 1998 May; 280(5368):1383-7. PubMed ID: 9603722
[TBL] [Abstract][Full Text] [Related]
19. The utility of animal models to evaluate novel anti-obesity agents.
Vickers SP; Jackson HC; Cheetham SC
Br J Pharmacol; 2011 Oct; 164(4):1248-62. PubMed ID: 21265828
[TBL] [Abstract][Full Text] [Related]
20. [Anti-obesity drugs: sibutramine and orlistat].
Sempere I Verdú E; Palop Larrea V; Hidalgo Mora JJ; Martínez-Mir I
Med Clin (Barc); 2002 Mar; 118(11):437; author reply 437-8. PubMed ID: 11943108
[No Abstract] [Full Text] [Related]
[Next] [New Search]